• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
COVID-19 and Women’s Health

Living Systematic Review and Meta-Analysis Update: COVID-19 and Pregnancy Outcomes

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • A ‘living’ systematic review was started in April 2020 to keep up with the latest literature on clinical manifestations of covid-19 in pregnancy and is updated regularly as new data becomes available
  • Allotey et al. (BMJ, 2020) provides the latest update on clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed COVID-19

METHODS:

  • Systematic review and meta-analysis
  • Data sources
    • Medline | Embase | Cochrane database | WHO COVID-19 database | China National Knowledge Infrastructure (CNKI) | Wanfang databases from December 1, 2019 to October 6, 2020
    • Preprint servers | Social media | Reference lists
  • Inclusion criteria
    • Cohort studies
    • Studies that reported the rates clinical manifestations (symptoms, laboratory and radiological findings), risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed COVID-19
  • Study design
    • At least two researchers independently extracted the data and assessed study quality
    • Random effects meta-analysis was performed, with estimates pooled as odds ratios (OR) and proportions with 95% confidence intervals

RESULTS:

  • 192 studies
  • 10% of pregnant and recently pregnant women attending or admitted to hospital for any reason were diagnosed as having suspected or confirmed COVID-19 (73 studies; 67,271 women)
  • Most common clinical manifestations of COVID-19 in pregnancy
    • Fever: 40%
    • Cough: 41%
  • Pregnant and recently pregnant women vs nonpregnant women were overall
    • Less likely to have symptoms OR 0.28 (95% CI, 0.13 to 0.62)
    • Were less likely to report these specific symptoms
      • Fever: OR 0.49 (95% CI, 0.38 to 0.63)
      • Dyspnea: OR 0.76 (95% CI, 0.67 to 0.85)
      • Myalgia: OR 0.53 (95% CI, 0.36 to 0.78)
  • Pregnant and recently pregnant women vs nonpregnant women had higher odds of
    • ICU admission: OR 2.13 (95% CI, 1.53 to 2.95)
    • Invasive ventilation: OR 2.59 (95% CI, 2.28 to 2.94)
    • ECMO: OR 2.02 (95% CI, 1.22 to 3.34)
  • Overall mortality
    • Pregnant women with confirmed COVID-19: 0.02% died from any cause
  • The following maternal characteristics were associated with severe COVID-19 in pregnancy
    • Increased maternal age
      • OR 1.83 (95% CI, 1.27 to 2.63)
    • High BMI
      • OR 2.37 (95% CI, 1.83 to 3.07)
    • Pre-existing maternal comorbidity
      • OR 1.81 (95% CI, 1.49 to 2.20)
    • Chronic hypertension
      • OR 2.0 (95% CI, 1.14 to 3.48)
    • Pre-existing diabetes
      • OR 2.12 (95% CI, 1.62 to 2.78)
    • Preeclampsia
      • OR 4.21 (95% CI, 1.27 to 14.0)
  • The following were associated with serious complications such as ICU admission, invasive ventilation and maternal death
    • Increased maternal age
    • High BMI
    • Non-white ethnicity
    • Pre-existing maternal comorbidity including chronic hypertension and diabetes
    • Preeclampsia
  • Compared to pregnant women without COVID-19, those with the disease had increased odds of
    • Maternal death: OR 2.85 (95% CI, 1.08 to 7.52)
    • ICU: OR 18.58 (95% CI 7.53 to 45.82); I2=0%
    • Preterm birth: OR 1.47 (95% CI 1.14 to 1.91); I2=18.6%
  • The odds of NICU admission were higher in babies born to mothers with COVID-19
    • OR 4.89 (95% CI, 1.87 to 12.81)

CONCLUSION:

  • While pregnant and recently pregnant women vs nonpregnant women with COVID-19 who attended or were admitted to a hospital were less likely to have symptoms such as fever, dyspnea or myalgias, they were more likely to be admitted to the ICU or need invasive ventilation
    • There may be a higher risk of maternal death
  • Pregnant women with COVID-19 were more likely to deliver preterm, and their infants were more likely to be admitted to the NICU
  • Non-white ethnicity, chronic hypertension, preexisting diabetes, high maternal age, and high BMI were risk factors for severe COVID-19 in pregnancy
  • The authors due temper their results based on the quality of the data

Our review update also identified an increased risk for maternal death, need for maternal admission to the intensive care unit, and stillbirth in pregnant women with covid-19 compared to pregnant women without the disease

However, our confidence in these estimates is not high, owing to the small numbers of events in both groups

Further data are still needed to robustly assess these outcomes, along with the emerging data on increased risk of severe outcomes such as the need for ECMO

Learn More – Primary Sources:

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis

Get COVID-19 Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19 and Women’s Health Posts
Next >

Related ObG Topics:

COVID-19 & Pregnancy Cases: Updated Primary Scientific Reports with Professor Jim Thornton
Coronavirus and Pregnancy: CDC Guidance and Professional Recommendations
Update from the UKOSS Registry: The Latest Outcomes Among Hospitalized Pregnant Women with COVID-19

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site